TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|---|---|---|---|---|---|---|---|---|---|---|
P | %ret | 1 | 1 | 1 | -2 | 4 | 33 | 56 | 42 | -39 | 16 |
P | %wins | 0 | 100 | 100 | 100 | 100 | 0 | 67 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/22/20 16:09 | 5/20/20 | TXG | 10X Genomics, Inc. | DE | Electr | LabEq | Laboratory Analytical Instrum | Venrock Associates Vi, L.P. | CA | T | S.d | -79,058 | 78.00 | 0 | -1,014 | -44 | 1,288 | I | |||||||||||||||
8/7/14 15:17 | 8/5/14 | AAVL | Avalanche Biotechnologies, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Venrock Associates Vi, L.P. | CA | T | P.d | 6,800 | 17.00 | 33 | 400 | 20 | 2,365 | I | -7 | -2 | 4 | 33 | 56 | 42 | -39 |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |